Cell and Gene Therapy Catapult

news

UK government invests £100 million into COVID-19 vaccine manufacturing

27 July 2020 | By Victoria Rees (European Pharmaceutical Review)

The UK government has committed £100 million to establish a centre to scale up COVID-19 vaccine and gene therapy manufacturing.

news

UK accounts for 12 percent of global cell and gene therapy clinical trials

17 January 2020 | By Victoria Rees (European Pharmaceutical Review)

New research has found that the cell and gene therapy clinical environment in the UK has encouraged commercial sponsorship from around the world.

news

Investment in UK cell and gene therapy manufacturing set to continue

6 December 2019 | By Hannah Balfour (European Pharmaceutical Review)

An additional 6,000m2 of cell and gene therapy manufacturing space is expected to become available within the next 12 months, according to new data.

news

Positive interim review in ongoing AML WT1 T cell clinical trial

14 April 2016 | By Victoria White, Digital Content Producer

The Cell and Gene Therapy Catapult has announced a positive interim review of a Phase I/II trial using WT1-TCR t-cell therapy to target acute myeloid leukaemia...